查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423202

2024-2032 年按产品类型（生物保存设备、生物保存介质）、应用（治疗应用、生物库应用、药物发现应用）和区域分類的生物保存市场报告

Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球生物防腐市场规模达77亿美元。展望未来， IMARC Group预计到2032年市场规模将达到193亿美元，2024-2032年复合年增长率（CAGR）为10.4%。大众对个人化医疗的日益关注、研发（R&D）活动投资的增加以及对罕见疾病的认识和理解的不断提高是推动市场的一些主要因素。

生物保存是指长时间保存生物材料（例如细胞、组织、器官或整个生物体）处于可行和功能状态的过程。该过程的目标是保持生物材料的完整性、活力和功能性，使其能够储存、运输和用于各种目的，包括研究、临床应用和工业过程。它在各个领域都有广泛的应用，包括医学、生物技术以及用于储存细胞、组织和器官以进行移植、再生医学和药物开发的研究。

全球市场的主要驱动力是大众对个人化医疗的日益关注。此外，政府、学术机构和私人组织在生命科学、生物技术和医疗保健领域对研发（R&D）活动的​​投资不断增加，也为市场提供了推动力。此外，随着个体对罕见疾病和遗传性疾病的认识和理解不断提高，越来越需要保存受影响群体的生物样本。这些技术支援收集和储存这些样本，用于研究疾病机制、开发诊断方法和促进标靶治疗的开发，从而满足全球的需求。此外，改进的冷冻保护剂、自动化系统和增强的储存协议的开发正在扩大生物保存的能力和应用，因为它们有助于维持保存的生物材料的效率、可靠性和安全性，进一步创造积极的市场前景。

生物保存市场趋势/驱动因素：

对生物样本库的需求不断增加

生物样本库需求的不断增长对全球市场产生了重大影响。生物样本库是储存各种生物样本的储存库，包括细胞、组织、血液、DNA 和其他生物材料，用于研究和诊断目的。这些技术在维持这些样本的完整性、可行性和功能性、确保其长期储存和可用性方面发挥着至关重要的作用。对大规模人群研究、临床试验和研究项目的需求不断增长，这些研究、临床试验和研究项目需要多样化且保存完好的生物样本，这正在影响全球整个生物样本库领域。此外，对精准医疗和个人化医疗保健的日益关注放大了生物样本库的重要性，因为它们提供了全面的样本集合，可用于基因组测试、生物标记发现和客製化治疗的开发。

再生医学的不断进步

再生医学的进步对全球市场产生重大影响。生物保存透过保留细胞、组织和工程结构的活力和功能，在再生医学的成功中发挥着至关重要的作用，因为再生医学的目标是使用基于细胞的疗法、组织工程和其他创新方法来恢復或替换受损的组织或器官。 。此外，这些技术对于在储存和运输过程中维持干细胞的活力和效力至关重要。冷冻和玻璃化等冷冻保存方法通常用于保存干细胞以供将来在治疗或研究中使用。干细胞保存方案和冷冻保护剂的进步增强了干细胞的活力和解冻后功能，促进了市场的成长。

生物製药产业的扩张

生物製药产业的扩张是影响市场的重要因素。生物製药产业专注于生物药物的开发和生产，包括治疗性蛋白质、抗体、疫苗和细胞疗法。生物保存在确保这些复杂生物产品从开发到分销的整个生命週期的稳定性、品质和完整性方面发挥着至关重要的作用。由于生物药物对温度、光线和湿度等环境条件高度敏感，对这些技术的需求大幅增加，因为它们对于维持这些药物在储存和运输过程中的稳定性和品质至关重要。透过采用冷冻保存、冷冻干燥或其他适当的保存方法，生物製药公司可以延长其产品的保质期，并确保其在给患者服用时的有效性和安全性。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物保存市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依产品类型
  • 市场区隔：按应用
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第 6 章：市场区隔：依产品类型

  • 生物保存设备
    • 市场走向
    • 市场预测
  • 生物保存介质
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 治疗应用
    • 市场走向
    • 市场预测
  • 生物样本库应用
    • 市场走向
    • 市场预测
  • 药物发现应用
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测

第 9 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BioLife Solutions, Inc.
    • Thermo Fisher Scientific Inc.
    • VWR International, LLC
    • Panasonic Corporation
    • BioCision LLC
Product Code: SR112024A829

Abstract

The global biopreservation market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2024-2032. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.

Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.

The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.

Biopreservation Market Trends/Drivers:

Increasing Demand for Biobanking

The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.

Continual Advancements in Regenerative Medicine

Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.

The Expansion of the Biopharmaceutical Industry

The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.

Biopreservation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biopreservation market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type and application.

Breakup by Product Type:

Biopreservation Equipment

Biopreservation Media

Biopreservation equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment and media. According to the report, biopreservation equipment represented the largest segment.

Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.

On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.

Breakup by Application:

Therapeutic Applications

Biobank Applications

Drug Discovery Applications

Biobank applications hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes therapeutic applications, biobank applications, and drug discovery applications. According to the report, biobank applications accounted for the largest market share.

Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.

On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.

Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.

On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.

Competitive Landscape:

Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

BioLife Solutions, Inc.

Thermo Fisher Scientific Inc.

VWR International, LLC

Panasonic Corporation

BioCision LLC

Recent Developments:

In June 2023, BioLife Solutions, Inc. introduced a new, large-capacity controlled-rate freezer (CRF) in order to expand its CRF product line. This new product will allow the company to support autologous and allogeneic CGT customers and its commercial-scale manufacturing as well as fulfills crucial customer needs to perform high-volume cell therapies.

In Jan 2023, Thermo Fisher Scientific Inc. completed its mergers and acquisition (M&A) agreement with The Binding Site Group ("The Binding Site"), a global leader in specialty diagnostics in order to expand its existing specialty diagnostics portfolio and include pioneering innovation in diagnostics and monitoring for multiple myeloma.

PHC Holdings Corporation announced in 2023 that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd., making SciMed a wholly owned subsidiary of PHCHD. This acquisition will assist in expanding the life sciences business of the company across the Asia-Pacific region.

Key Questions Answered in This Report

  • 1. What was the size of the global biopreservation market in 2023?
  • 2. What is the expected growth rate of the global biopreservation market during 2024-2032?
  • 3. What are the key factors driving the global biopreservation market?
  • 4. What has been the impact of COVID-19 on the global biopreservation market?
  • 5. What is the breakup of the global biopreservation market based on the product type?
  • 6. What is the breakup of the global biopreservation market based on the application?
  • 7. What are the key regions in the global biopreservation market?
  • 8. Who are the key players/companies in the global biopreservation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biopreservation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Biopreservation Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biopreservation Media
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Applications
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biobank Applications
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Discovery Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Competitive Landscape

  • 9.1 Market Structure
  • 9.2 Key Players
  • 9.3 Profiles of Key Players
    • 9.3.1 BioLife Solutions, Inc.
    • 9.3.2 Thermo Fisher Scientific Inc.
    • 9.3.3 VWR International, LLC
    • 9.3.4 Panasonic Corporation
    • 9.3.5 BioCision LLC

List of Figures

  • Figure 1: Global: Biopreservation Market: Major Drivers and Challenges
  • Figure 2: Global: Biopreservation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biopreservation Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biopreservation Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Biopreservation Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Biopreservation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Biopreservation Industry: SWOT Analysis
  • Figure 8: Global: Biopreservation Industry: Value Chain Analysis
  • Figure 9: Global: Biopreservation Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Biopreservation Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biopreservation Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biopreservation Media Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biopreservation Media Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biopreservation (Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biopreservation (Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biopreservation (Biobank Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biopreservation (Biobank Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biopreservation (Drug Discovery Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biopreservation (Drug Discovery Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: North America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: North America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Europe: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Europe: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Asia Pacific: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Asia Pacific: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Latin America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Latin America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Biopreservation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Biopreservation Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biopreservation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biopreservation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biopreservation Market: Competitive Structure
  • Table 6: Global: Biopreservation Market: Key Players